Mark J. Levin, Director at MILLENNIUM PHARMACEUTICALS INC (MLNM), sold 2,600 shares at $16.44 ($42K) on 2008-01-02, disclosed to the SEC on 2008-01-03.
Scheduled sale ($42k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.68 | 100 | $2K | 3.7% |
| 2 | $16.00 | 100 | $2K | 3.8% |
| 3 | $16.07 | 200 | $3K | 7.6% |
| 4 | $16.12 | 100 | $2K | 3.8% |
| 5 | $16.15 | 100 | $2K | 3.8% |
| 6 | $16.21 | 200 |
| $3K |
| 7.7% |
| 7 | $16.24 | 200 | $3K | 7.7% |
| 8 | $16.26 | 100 | $2K | 3.8% |
| 9 | $16.27 | 100 | $2K | 3.8% |
| 10 | $16.30 | 200 | $3K | 7.7% |
| 11 | $16.31 | 200 | $3K | 7.7% |
| 12 | $16.32 | 100 | $2K | 3.9% |
| 13 | $16.41 | 300 | $5K | 11.6% |
| 14 | $16.43 | 200 | $3K | 7.8% |
| 15 | $16.44 | 100 | $2K | 3.9% |
| 16 | $16.47 | 100 | $2K | 3.9% |
| 17 | $16.48 | 100 | $2K | 3.9% |
| 18 | $16.52 | 100 | $2K | 3.9% |
| Total | $16.27 avg | 2,600 | $42K | 100% |
| Filing → |
| MLNM | SELL | 2008-01-10 | $29K | — | Filing → |
| MLNM | SELL | 2008-01-10 | $122K | — | Filing → |
| MLNM | SELL | 2008-01-03 | $120K | — | Filing → |